Tissue Equivalent Tubular Scaffold Densification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing tissue equivalent scaffolds, particularly for human-sized tubular structures, face limitations such as mechanical weakness, rapid degradation, and variability in biological and mechanical properties, making it challenging to create large-scale, thick-walled constructs suitable for clinical applications.
Innovation Solution
A method involving a casting chamber with an elongate mould portion and a lumen template, where a gel casting material is partially filled and allowed to densify through restricted axial flow, either via a flow-limiting member or a porous end, enabling the production of human-sized tubular scaffolds with enhanced mechanical strength and reproducibility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If natural polymeric scaffolds (e.g., collagen gel) are used, then biocompatibility and cellular interactions are improved, but mechanical strength and structural stability deteriorate
Solution Approach 1:
The patent applies parameter changes by controlling the water content and density of collagen scaffolds through a controlled drying process. The scaffold is dried to a specific moisture content (5-20%) to achieve optimal mechanical strength while maintaining biocompatibility. This parameter optimization resolves the contradiction between soft natural polymer properties and required mechanical strength.
Solution Approach 2:
The patent creates composite materials by combining collagen with synthetic polymers or crosslinking agents to enhance mechanical properties. The composite structure maintains the biocompatibility of natural collagen while incorporating materials that provide superior mechanical strength and structural stability for tubular constructs.
2Shape
If decellularized scaffolds are used, then tissue-specific structure is preserved, but donor availability and pathogen transmission risks worsen
Solution Approach 1:
The patent uses synthetic polymers that can be manufactured without donor tissue, eliminating pathogen transmission risks. These synthetic scaffolds serve as disposable, pre-fabricated structures that can be sterilized and implanted without requiring decellularization processes, thus resolving the safety concerns while maintaining structural integrity.
3Strength
If thick-walled tubular scaffolds are produced for human-sized applications, then mechanical strength is improved, but manufacturing complexity and difficulty increase
Solution Approach 1:
The patent applies preliminary action by pre-forming the tubular scaffold structure with the desired wall thickness and geometry before implantation. The scaffold is manufactured as a complete, thick-walled structure using controlled drying and molding techniques, eliminating the need for complex post-implantation assembly or reinforcement procedures.
Solution Approach 2:
The patent uses a three-dimensional drying approach where water is removed from the collagen matrix in a controlled manner to create uniform thick walls. The dimensional control during drying allows production of human-sized tubular scaffolds with consistent wall thickness, simplifying manufacturing while achieving the required mechanical strength.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for the production of thick-walled, human-sized tubular scaffolds with mechanical properties comparable to native tissue, offering improved strength and reproducibility, and the ability to create seamless structures suitable for various medical applications.
Implementation Method 1
allowing restricted axial flow of the fluid phase of the gel casting material out of the elongate mould portion, thereby densifying gel casting material within the elongate mould portion
Implementation Method 2
at least part of the closed end of the elongate mould portion of the casting chamber is porous; allowing axial flow of the fluid phase of the gel casting material out of the porous end part
Data Source
AI summary
The present invention provides tissue equivalent scaffold structures and methods of production thereof. Such methods include providing a casting chamber comprising an elongate mould portion, axially disposing a lumen template within the elongate mould portion, and at least partly filling the casting chamber with a gel casting material comprising a matrix of fibrils or fibres and an interstitial fluid phase, such that a portion of the lumen template extends above the casting material. The fluid phase of the gel is allow to flow axially out of the elongate mould portion, in a restricted manner, thereby resulting in axial densification of the gel casting material to form a tissue equivalent tubular scaffold. Tissue equivalent scaffold structures according to the present invention are able to support cell populations both within the walls and on the surface of the construct. They have enhanced mechanical strength due to increased collagen density, and are customisable in terms of luminal diameter and wall thickness. They may find application in tubular tissue engineering.